dosing
Articles tagged with “dosing”
Ketamine Dosage Guide: Ranges, Forms, and How Doses Are Set
How ketamine dosage is set: typical ranges by form (IV, IM, intranasal, oral), what influences your dose, and why protocols are individualized. Patient educa...
Ketamine Troche Dosage: A Patient Reference Guide
Typical sublingual ketamine troche dosage ranges, how lozenges are dosed for depression and maintenance, what to know about increments, and key safety considerations.
PHQ-9 and GAD-7 in Ketamine Dose Adjustment: A Patient Guide
Learn how PHQ-9 and GAD-7 assessments guide ketamine dose adjustments. Patient-focused guide to understanding symptom tracking and dosing decisions.
When to Switch or Stay: NMDA Therapy Discontinuation Rates
New analysis reveals why patients stop NMDA receptor antagonist therapy—and what discontinuation data means for low-dose ketamine monitoring and dosing decisions.
What Dropout Rates Reveal About NMDA Therapy Tolerability
New psychiatric guidance examines why patients stop NMDA antagonist therapy and what side effect data means for low-dose ketamine treatment decisions.
When Ketamine Side Effects Signal Time to Adjust Dose
New clinical analysis examines why patients stop NMDA antagonist therapy—and how smarter dose management may improve remission outcomes in TRD.
Faster TRD Remission Hinges on Measurement and Dose Timing
New analysis in Psychiatric Times shows that symptom tracking and rapid dose adjustment drive faster remission in TRD—here's what it means for ketamine care.
What Side Effect Data Tells Us About Ketamine Dosing
New analysis of NMDA receptor antagonist side effects in treatment-resistant depression underscores why dose optimization and early monitoring matter.
NMDA Antagonist Side Effects: What the Data Says
New clinical analysis examines why patients stop ketamine and esketamine treatment—and what smarter monitoring can do to keep them on track.
Ketamine Side Effects & When to Switch: New Clinical Guidance
New clinical guidance urges tracking PHQ-9 scores, monitoring side effects closely, and switching NMDA treatments sooner to reach remission faster.
Microdosing Ketamine Protocols: Sub-Therapeutic Dose Approaches
What does ketamine microdosing involve? Review of dose ranges, clinical applications, safety considerations, and how it differs from standard low-dose care.
Low-Dose Ketamine Case Studies: Clinical Outcomes and Lessons
What do published low-dose ketamine case studies show? Review of clinical outcomes, dosing patterns, and lessons across depression, pain, and anxiety cases.
Dosing and Administration
Common questions about ketamine dosing, routes of administration, weight-based calculations, dose adjustments, and the differences between clinic and at-home treatment.
Ketamine Dosing and Administration: A Complete Clinical Guide
Reference guide to ketamine dosage across IV, oral, sublingual troche, and intranasal routes — weight-based dosing, titration, and route-specific protocols.
How Many Ketamine Treatments Are Needed?
How many ketamine sessions does a typical course take? Review of 6-infusion induction, maintenance scheduling, and response data on course length.
What Is the Standard Ketamine Dose for Depression?
What is the standard ketamine dose for depression? 0.5 mg/kg IV over 40 minutes, plus how oral and sublingual low-dose protocols translate from that baseline.
Ketamine Tolerance: Understanding Dose Adjustments Over Time
Do patients build tolerance to ketamine? A clinical review of tolerance mechanisms, clinical signs, and evidence on adjusting dose over repeated treatment.
Pediatric Low-Dose Ketamine: Dosing Considerations and Safety
Review of pediatric low-dose ketamine dosing considerations, covering developmental pharmacokinetics, age-specific safety data, and clinical applications in children and adolescents.
Esketamine vs Racemic Ketamine Dosing: Comparative Pharmacology
How do esketamine and racemic ketamine doses compare? Review of enantiomer pharmacology, potency differences, route-specific dosing, and clinical equivalencies.
Weight-Based Dosing Guidelines for Low-Dose Ketamine
Practical guidance on weight-based dosing calculations for low-dose ketamine across clinical indications. Addresses ideal versus actual body weight considerations, dosing ranges by route and indication, and special population adjustments.
Standard IV Ketamine Infusion Protocols for Treatment-Resistant Depression
How are IV ketamine infusions dosed for treatment-resistant depression? Review of 0.5 mg/kg standard, session structure, monitoring, and evidence base.
Geriatric Considerations in Low-Dose Ketamine Therapy
Is ketamine therapy safe for elderly patients? Review of age-related pharmacokinetics, cardiovascular risk, cognitive monitoring, and low-dose adjustments.
Renal and Hepatic Dose Adjustments for Low-Dose Ketamine
How is low-dose ketamine adjusted for kidney or liver impairment? Review of pharmacokinetic rationale, dose modification, and monitoring in at-risk patients.
Defining Sub-Anesthetic Ketamine: Dose Ranges and Therapeutic Windows
Comprehensive guide to sub-anesthetic ketamine dose ranges and therapeutic windows, covering pharmacological thresholds, receptor occupancy, and clinical dose-response relationships.
Dose-Response Relationships in Low-Dose Ketamine Therapy
An in-depth examination of ketamine dose-response curves across indications including depression, chronic pain, and procedural analgesia. Covers threshold doses, ceiling effects, and how response varies with clinical context.
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.